This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AIG APA BHI PGR BBBY

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

American International (AIG - Get Report) rated new Neutral at Nomura. $46 price target. Company may struggle to generate strong ROE.

Apache (APA - Get Report) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $105 price target. Company can drive significant change through restructuring.

Bed Bath & Beyond (BBBY - Get Report) upgraded at Nomura to Buy from Neutral, said Nomura. Merchandising, the Keurig overhang and margins are all improving. Price target goes to $82.

Baker Hughes (BHI - Get Report) upgraded at Jefferies from Hold to Buy, Jefferies said. $54 price target. Higher pressure pumping sales should drive margin expansion.

Citrix Systems (CTXS) upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Sector is cheap and the company is leveraged to an acceleration of growth in the second half of the year.

Forest Laboratories (FRX) upgraded at Argus from Hold to Buy, Argus said. $46 price target. Namenda should drive near-term growth.

Joy Global (JOY) downgraded at Goldman to Neutral, said Goldman Sachs. The firm's model underestimated declines in mining equipment share of capex and visibility on the commodity recovery remains clouded.

US Airways (LCC) downgraded at BofA/Merrill to Underperform, Bank of America/Merrill Lynch said. $16 price target. Estimates also cut, given lower expected AMR results.

Occidental Petroleum (OXY) downgraded at Sterne Agee to Neutral, Sterne Agee said. Valuation call, based on a $97 price target.

Progressive (PGR - Get Report) rated new Reduce at Nomura. Valuation call, based on a $20 price target.

QEP Resources (QEP) upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $36 price target. Company is executing well in the Bakken, expanding its midstream business and is leveraged to firming gas prices.

Standard Pacific (SPF) rated new Buy at BofA/Merrill SPF was initiated with a Buy rating, BofA/Merrill Lynch said. $11 price target. Company has better pricing and margins that its peers.

Timken (TKR) upgraded at Jefferies to Buy, Jefferies said. $65 price target. Company is attractive, based on a sum-of-the-parts valuation.

STOCK COMMENTS / EPS CHANGES

ABM Industries (ABM) numbers upped at Jefferies through 2014, Jefferies said. Janitorial demand is driving strong organic growth. Buy rating and new $29 price target.

Axiall Corp (AXLL) estimates reduced at UBS on lower PVC volumes and margins, said UBS.

Salesforce.com (CRM) added to Americas Conviction List at Goldman. The company is taking share in the customer relationship management market and upside is expected to current bookings forecast.

Dollar General (DG) numbers cut at BMO. Shares of DG now seen reaching $58, according to BMO Capital. Estimates also reduced, given the company's new guidance. Outperform rating.

Hospira (HSP) price target raised at UBS to $37 to reflect lowers costs as Precedex goes generic, the removal of manufacturing issues, and benefits from the low cost facility in India, said UBS.

MarketAxess (MKTX) estimates, target increased at Credit Suisse. MKTX estimates were raised through 2015, Credit Suisse said. Company is leveraged to healthier fixed income markets.

STRATEGY CALLS / MARKET CALLS

S&P 500 target raised at Credit Suisse to 1730 from 1640, Credit Suisse said. Too much pessimism on impact of tapering and attractive relative valuation.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
AIG $59.10 0.63%
APA $43.22 0.21%
BHI $54.74 0.66%
BBBY $62.00 1.87%
PGR $29.67 1.47%

Markets

Chart of I:DJI
DOW 16,351.38 +293.03 1.82%
S&P 500 1,948.86 +35.01 1.83%
NASDAQ 4,749.9790 +113.8740 2.46%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs